Drug may be major advance as malaria has developed resistance to existing treatments
Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world’s best hopes for treating and preventing malaria — a disease that kills more than one million people each year.
The scientists have described the drug, and its effectiveness against mice infected with malaria, in the March 20 issue of Science Translational Medicine, an interdisciplinary journal of the American Association for the Advancement of Science.
The drug — called ELQ-300 — “is an exciting compound as it ticks a number of boxes necessary in a next-generation antimalarial,” said Dr. Timothy Wells, the chief scientific officer for Medicines for Malaria Venture, a Swiss non-profit that is leading the scientific fight against malaria and that helped fund the research leading to ELQ-300. “It has potential to become part of a combination therapy that could cure patients, prevent infection and block the transmission of malaria — all at low-doses — which means fewer and smaller pills for patients, at a lower cost. Provided a formulation can be developed, ELQ-300 holds great promise to become a tool to help shrink the malaria map.”
Malaria infects more than 200 million people per year and kills more than 1.2 million — many of them children under 6 and many of them living in Africa.
The two main drugs that have been used to treat malaria over the last several decades — quinine and chloroquine — have become less effective as the parasite that causes malaria has become resistant to the drugs.
As described in Science Translational Medicine, ELQ-300 was extremely potent against malaria in mice. It also has another distinct advantage: it targets the parasite that causes malaria much earlier in the process than existing drugs do. Most of the drugs in clinical use today target a form of the parasite only after it has unloaded millions or even billions of “merozoites” into the human bloodstream. ELQ-300 targets the parasite earlier when it is in the liver, and when its numbers are much lower, before anything has spilled into the bloodstream.
That means the drug can be incredibly potent and may be able to not only treat malaria in a single dose, but also prevent malaria before any serious disease symptoms develop.
“We believe ELQ-300 has a chance to change the landscape of how we fight malaria across the world,” said Michael Riscoe, Ph.D., principal investigator in the research, a professor of molecular microbiology and immunology at OHSU and director of the Experimental Chemotherapy Lab at the Portland VA Medical Center.
One distinct advantage of the drug could be its potency — that it could treat malaria in a single dose. A major problem with existing malaria drugs is that they require multiple doses over a number of days to achieve a cure. If people miss a dose, that means the drug won’t work, and it allows the parasite to develop resistance against the drug, Riscoe said.
With a drug that only requires a single dose, a medical professional or aid worker can observe a person taking the medicine to ensure compliance.
Any new anti-malarial drug also would become part of a drug “cocktail” and be used in combination with other drugs to prevent the emergence of resistance, Riscoe said.
Malaria is a major health problem in tropical areas. It accounts for 40 percent of all public health spending in Africa. It also presents a major disease hazard to travelers in the tropics and subtropics.
The Latest Bing News on:
Malaria
- AKO Foundation Takes Bold Steps to Combat Plastic Pollution and Malaria in Amasaman Communityon May 17, 2024 at 8:56 am
AKO Foundation, a prominent environmental advocacy organization, is pleased to announce the successful completion of its project addressing the intertwined challenges of plastic pollution and malaria ...
- ‘Malaria Elimination Initiative’ launched in Region Oneon May 17, 2024 at 2:15 am
MARKING a major advancement in the fight against malaria in the country by enhancing the health and well-being of residents, the Government of Guyana, through the Ministry of Health, launched the ...
- Professional Faqs: How Can We Prevent Malaria?on May 16, 2024 at 2:28 pm
Expert opinion from Afra Abdussamad MBBS · 3.5 years of experience · India Malaria is a potentially life-threatening parasitic disease caused by infection with Plasmodium protozoa transmitted by an ...
- Fight to eradicate malaria takes associate professor to Equatorial Guineaon May 16, 2024 at 2:21 pm
Malaria eradication is a passion of Giri Athrey, Ph.D., who is working with Bioko Island Malaria Elimination Project in Equatorial Guinea.
- Landscape drives zoonotic malaria prevalence in non-human primateson May 16, 2024 at 8:44 am
Regional meta-analysis enriches our understanding of zoonotic malaria in primate reservoirs in areas of Southeast Asia experiencing deforestation, with wider ecological implications for human disease ...
- SMART breakthrough research identifies mechanism behind drug resistance in malaria parasiteon May 15, 2024 at 5:00 pm
Malaria is a mosquito-borne infectious disease that remains a significant global health threat. In 2022, it afflicted 249 million people and caused 608,000 deaths globally. Artemisinin (ART) -based ...
- African regions at risk for malaria transmission may decline more than previously expectedon May 9, 2024 at 9:25 pm
Areas at risk for malaria transmission in Africa may decline more than previously expected because of climate change in the 21st century, suggests an ensemble of environmental and hydrologic models.
- FDA considers updating blood donation guidelines to keep nation’s supply safe from malariaon May 9, 2024 at 4:09 pm
The US Food and Drug Administration is considering a requirement for blood banks to use a new test that can detect the parasites that cause malaria in certain donors’ blood, and it’s seeking the ...
- How climate change will affect malaria transmissionon May 9, 2024 at 11:01 am
A new model for predicting the effects of climate change on malaria transmission in Africa could lead to more targeted interventions to control the disease according to a new study.
- Patriots’ Calvin Anderson Was Given 50% Chance to Live After Contracting Malaria Last Yearon May 8, 2024 at 11:10 am
Chris Unger/Getty New England Patriots player Calvin Anderson is lucky to be alive after a life-threatening battle with malaria. The NFL player, 28, revealed in an interview with the Boston Globe that ...
The Latest Google Headlines on:
Malaria
[google_news title=”” keyword=”malaria” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Malaria drug
- Malaria cases dip, hosp strives to find patients for drug trialon May 17, 2024 at 4:37 pm
However, the dip in number has posed a challenge for Chittaranjan National Medical College and Hospital (CNMCH) authority, which has taken up a clinical trial of malaria drug primaquine under the ...
- Professional Faqs: How Can We Prevent Malaria?on May 16, 2024 at 2:28 pm
Expert opinion from Afra Abdussamad MBBS · 3.5 years of experience · India Malaria is a potentially life-threatening parasitic disease caused by infection with Plasmodium protozoa transmitted by an ...
- Research identifies mechanism behind drug resistance in malaria parasiteon May 16, 2024 at 8:15 am
Collaborating researchers have discovered a link between malaria parasites' ability to develop resistance to antimalarial drugs—specifically artemisinin (ART)—through a cellular process called ...
- SMART breakthrough research identifies mechanism behind drug resistance in malaria parasiteon May 15, 2024 at 5:00 pm
Malaria is a mosquito-borne infectious disease that remains a significant global health threat. In 2022, it afflicted 249 million people and caused 608,000 deaths globally. Artemisinin (ART) -based ...
- Malaria still poses health riskson May 13, 2024 at 10:17 pm
Signs and symptoms of malaria can include: Malaria is treated with prescription drugs to kill the parasite. The types of drugs and the length of treatment will depend on the type of malaria ...
- Path to a zero malaria world: a new type of net could cut risk of the mosquito-borne disease by halfon May 13, 2024 at 5:00 pm
We track the journey of how the mosquito first gets infected and how it passes the disease on to a human being.
- FDA considers updating blood donation guidelines to keep nation’s supply safe from malariaon May 9, 2024 at 4:09 pm
The US Food and Drug Administration is considering a requirement for blood banks to use a new test that can detect the parasites that cause malaria in certain donors’ blood, and it’s seeking the ...
- How climate change will affect malaria transmissionon May 9, 2024 at 11:01 am
A new model for predicting the effects of climate change on malaria transmission in Africa could lead to more targeted interventions to control the disease according to a new study.
- GHIT Fund invests Y1.54bn in malaria and NTD drug projectson May 9, 2024 at 3:51 am
The Global Health Innovative Technology (GHIT) Fund has announced an investment of Y1.64bn ($10.8m) in four new projects aimed at developing drugs to treat malaria and neglected tropical diseases ...
- An Engineered Antibody Can Prevent Malariaon May 8, 2024 at 5:34 am
Mosquitoes are one of the deadliest animals on earth because they transmit diseases including malaria, which is thought to be responsible for the deaths of... | Microbiology ...
The Latest Google Headlines on:
Malaria drug
[google_news title=”” keyword=”malaria drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]